Our previous studies identified interleukin (IL)-27 as a novel inhibitory cytokine of HIV-1 produced by cervical cancer vaccine-treated macrophages [18], which induces multiple IFN-stimulated genes, including host factors, via an IFN-independent mechanism [19, 20]. The gene discussed is IFNA1; the disease is cervical carcinoma.